Blockbuster Drug Development, and Upstarts Becoming UpstartsGLOBAL PHARMA INDUSTRY-Uncovering the Core of Drug Shortages in the United States-Generic Equivalent to Branded Drug, What Are the FactsNEW DRUG R&D-How to Select Blister Packaging ...
Cold chain services for clinical trial success This interactive infographic highlights Patheon’s capabilities for maintaining cold chain integrity across the supply chain. Utilizing our global network and expertise, our end-to-end cold chain management services can support your advanced clinical trial nee...
Given that the relevant policies have just been released and that both China and the United States may still engage in consultations on tariff issues in the future, we will continue to closely monitor the developments and update the anal...
macular edema (DME); the initial results of these studies served as the foundation for subsequent trials leading to the approval of these pharmacologic agents by the FDA and other regulatory authorities for the indicated diseases. Dr. Nguyen has chaired the United States multi-center READ-2, ...
Opcenter Execution Pharma 是一个制造执行系统 (MES),具有无纸化制造和药品电子批次记录 (eBR) 功能。联系我们,了解如何在购买此产品更改国家/地区致电我们+1 972 987 3090简化制药过程 Opcenter Execution Pharma 加快了必要的设计、执行和审查步骤,确保药品生产完全合规、记录完整。 使用主批次记录 (MBR) 驱动型...
unitedchem | schebo biotech | schircks laboratories | Scimedx | SCICONS | scientech corp | SSI Diagnostica | synabs | Simicon | somru bioscience | sierra bioresearch | rna medical | RIKEN | RELIATech | pfaltzand&bauer/pfaltzandbauer | proteos | Quanta Biosciences | Prozomix | precision ...
Westar, FluroTec, Envision, and Ready Pack are trademarks or registered trademarks of West Pharmaceutical Services, Inc. in the United States and other jurisdictions. FluroTec technology is licensed from Daikyo Seiko, Ltd. Related Blogs 一月21, 2021 ...
NovaPure, Ready Pack, LyoTec, Envision, FluroTec, LyoTec, and Westar are trademarks or registered trademarks of West Pharmaceutical Services, Inc. in the United States and other jurisdictions. D Sigma, RSV, and RUV are trademarks of Daikyo Seiko, Ltd. ...
主要目的是评估FP-208治疗晚期实体肿瘤患者的安全性和药代动力学特征,次要目的是初步评估抗肿瘤活性,并探索生物标志物pS6药物和疗效的关系。 开始日期2019-01-16 申办/合作机构 北京富龙康泰生物技术有限公司 100项与 北京富龙康泰生物技术有限公司 相关的临床结果 ...
United States Patent 6121434 Abstract: Oligonucleotides of the formula: 5'-(CAP)-(Oligo)-(CAP)-3' are disclosed where (oligo) is a nucleotide sequence of from 10 to 40 nucleotides in length, and CAP is Gm, where m is an integer of from zero to ten, the two CAP's which are present...